STOCK TITAN

Castle Biosciences Announces Grand Opening of New Corporate Headquarters in Friendswood, Texas

Castle Biosciences (Nasdaq: CSTL) will host a grand opening for its new corporate headquarters in Friendswood, Texas on March 24, 2026 at 3:00 p.m. CT.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Castle Biosciences (Nasdaq: CSTL) will host a grand opening for its new corporate headquarters in Friendswood, Texas on March 24, 2026 at 3:00 p.m. CT. The purpose-built 23-acre campus features energy-efficient systems, storm-rated design, flexible workspaces and employee amenities.

The facility supports Castle’s clinical testing operations and growth as the company advances its molecular test portfolio; Castle reported $344 million revenue in 2025. The event is by invitation; media may RSVP in advance.

Loading...
Loading translation...
Argus Mar 4 session
+2.18% close to close Open Argus
Details

News Market Reaction – CSTL

On Mar 4, the first trading day after this news, CSTL closed 2.18% above the previous close.

Data tracked by StockTitan Argus for the Mar 4 session.

Key Figures

Grand opening date/time: March 24, 2026 at 3:00 p.m. Central Campus address: 1500 West Parkwood Avenue Training center capacity: 48-seat training center +2 more
Grand opening date/time
March 24, 2026 at 3:00 p.m. Central
Headquarters grand opening event schedule
Campus address
1500 West Parkwood Avenue
Location of new Friendswood headquarters
Training center capacity
48-seat training center
Employee-focused amenity in new headquarters
Campus size
23-acre wooded campus
Size of Friendswood headquarters site
2025 revenue
$344 million
2025 revenue making CSTL one of largest in Galveston County

Historical Context

5 past events · Latest: Feb 26
5 events
  1. Feb 26

    Full-year 2025 results

    24h Move
    -7.3%

    Revenue beat guidance and strong core test growth but shares fell afterward.

  2. Feb 19

    Clinical validation data

    24h Move
    -6.8%

    Prospective JAAD study supported AdvanceAD-Tx performance, yet stock declined.

  3. Feb 05

    Earnings date announcement

    24h Move
    -7.3%

    Scheduled Q4 and 2025 earnings release and call details provided.

  4. Jan 11

    Preliminary 2025 results

    24h Move
    +0.8%

    Preliminary revenue above guidance and strong test volume growth modestly lifted shares.

  5. Dec 19

    Inducement equity grants

    24h Move
    -0.4%

    Employee RSU inducement grants under Nasdaq Rule 5635(c)(4) had limited impact.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

FRIENDSWOOD, Texas, March 03, 2026 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will host a grand opening celebration for its new corporate headquarters on Tuesday, March 24, 2026, at 3:00 p.m. Central time. The event will take place at the Company’s new campus located at 1500 West Parkwood Avenue in Friendswood, Texas, and will bring together employees, community partners and other invited guests to commemorate the completion of the purpose-built facility.

Local, state and national elected officials are expected to join the event, underscoring the significance of Castle’s investment in the region.

“Opening our new headquarters marks an important milestone for Castle Biosciences,” said Derek Maetzold, president and chief executive officer of Castle Biosciences. “The facility was built to empower our people, foster collaboration and support the innovations that will drive our future. It reflects our long-term focus on creating an environment where our teams can thrive and continue to make a meaningful difference for patients, as well as our enduring commitment to the Friendswood community that we are proud to call home.”

The new building features modern, flexible workspaces and advanced technology infrastructure designed to meet the Company’s evolving needs. The facility incorporates energy-efficient systems and storm-rated design elements to enhance sustainability and resilience. Employee-focused amenities include a private fitness center, a fourth-floor terrace designed for outdoor collaboration and overflow gatherings adjacent to a 48-seat training center, and a ground-level outdoor patio with a pergola and dedicated food truck pad. The 23-acre wooded campus features two walking trails, providing natural spaces that encourage movement and connection throughout the workday.

Castle, one of the largest publicly traded companies in Galveston County by revenue ($344 million in 2025), has long been an active supporter of the Friendswood community, contributing to local initiatives and partnerships that reflect its commitment to improving lives for patients and the community it calls home.

In addition to its Friendswood headquarters, Castle operates clinical laboratories in Phoenix and Pittsburgh. The new headquarters will support Castle’s continued growth as the Company advances its portfolio of innovative molecular tests in areas of high clinical need.

While this event is not open to the public, members of the media are welcome to attend and are encouraged to confirm attendance in advance by contacting Allison Marshall at amarshall@castlebiosciences.com.

About Castle Biosciences
Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company improving health through innovative tests that guide patient care. With a primary focus in dermatologic and gastroenterological disease, we develop personalized, clinically actionable solutions that help improve disease management and patient outcomes.

We put people first—empowering patients and clinicians and informing care decisions through rigorous science and advanced molecular tests that support more confident treatment planning. To learn more, visit www.CastleBiosciences.com and connect with us on LinkedIn, Instagram, Facebook and X. 

DecisionDx-Melanoma, DecisionDx-CMSeq, i31-SLNB, i31-ROR, DecisionDx-SCC, MyPath Melanoma, AdvanceAD-Tx, TissueCypher, DecisionDx-UM, DecisionDx-PRAME and DecisionDx-UMSeq are trademarks of Castle Biosciences, Inc.

Investor Contact:
Camilla Zuckero
czuckero@castlebiosciences.com

Media Contact:
Allison Marshall
amarshall@castlebiosciences.com

Source: Castle Biosciences, Inc.


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is Castle Biosciences (CSTL) holding the Friendswood headquarters grand opening?

The grand opening is scheduled for March 24, 2026 at 3:00 p.m. CT. According to the company, the invitation-only event will be held at 1500 West Parkwood Avenue in Friendswood and will include employees, community partners and elected officials.

What features does the new Castle Biosciences (CSTL) Friendswood headquarters include?

The new headquarters includes modern workspaces, a private fitness center and a 48-seat training center. According to the company, the 23-acre campus also has walking trails, a fourth-floor terrace, outdoor patio with food truck pad and energy-efficient, storm-rated systems.

How does the Friendswood HQ support Castle Biosciences' (CSTL) business operations?

The facility is designed to support collaboration, technology infrastructure and growth of molecular tests in clinical areas of need. According to the company, the purpose-built headquarters will enable teams and operations alongside labs in Phoenix and Pittsburgh.

Is the Castle Biosciences (CSTL) grand opening open to the public and how can media attend?

The event is not open to the public, but media are welcome to attend by prior confirmation. According to the company, media should RSVP in advance by contacting Allison Marshall at amarshall@castlebiosciences.com.

What recent revenue milestone did Castle Biosciences (CSTL) report that relates to the new headquarters?

Castle reported $344 million in revenue for 2025, indicating scale among local public companies. According to the company, that revenue figure underscores its presence in Galveston County and supports investment in the new headquarters.

Keep reading